Oamenii de știință de la USC au identificat enzima cPLA2 ca factor declanșator al inflamației în Alzheimer și au dezvoltat compuși terapeutici potențiali.

USC researchers have discovered that cPLA2, an enzyme involved in brain inflammation, may play a key role in Alzheimer's disease, particularly in individuals carrying the APOE4 high-risk gene. The team has identified potential drug compounds that could reduce this inflammation while preserving normal brain function.